SAN DIEGO, CA – Daré Bioscience, Inc., a biopharmaceutical company with a current market capitalization of $26.45 million and trading at $3.04 per share, is facing potential delisting from the Nasdaq ...

The rescission of SAB 121 unlocks institutional access to crypto, paving the way for a surge of traditional financial service ...

Most of our contacts are saying they are looking at their biggest pipeline in years.

Newmark (NMRK) bolstered its already robust capital markets business in 2024 and is poised for continued growth as interest rates stabilize in 2025, the company said in its quarterly earnings call ...

With a liquidity drought fading, investors can return to the more normal task of building private market portfolios designed ...

The major U.S. equity indexes were mixed Friday but closed an eventful week for earnings and data modestly higher.

Most believe improving economics will shift action in the venture industry away from building costly models to smaller models ...

Partner Insights spoke to Jay Sugarman to get more insight into his firm’s approach to ground leasing in the modern markets.

Asia’s “nascent capital market” needs a catalyst — but investors shouldn’t be deterred from investing in the region’s private ...

In 2024, returns were strong across stocks and bonds, but push out to two years, and the S&P 500 produced its highest return ...

KKR & Co.’s business of arranging financing for its portfolio companies and other firms reported record annual fees last year ...

Australia's Macquarie is set to shutter its U.S. debt capital markets arm, as it plans to focus its resources on private ...